Chemoinformaics analysis of 10-Chlorostrictosidine
Molecular Weight | 565.019 | nRot | 7 |
Heavy Atom Molecular Weight | 531.755 | nRig | 29 |
Exact Molecular Weight | 564.187 | nRing | 5 |
Solubility: LogS | -2.217 | nHRing | 4 |
Solubility: LogP | 0.95 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 1 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 9 | No. of Arom Bond | 10 |
nHA | 10 | APOL | 78.6922 |
nHD | 6 | BPOL | 42.5678 |
QED | 0.212 |
Synth | 4.92 |
Natural Product Likeliness | 1.951 |
NR-PPAR-gamma | 0.007 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.209 |
HIA | 0.776 |
CACO-2 | -5.68 |
MDCK | 0.0000169 |
BBB | 0.635 |
PPB | 0.722109 |
VDSS | 0.988 |
FU | 0.388852 |
CYP1A2-inh | 0.023 |
CYP1A2-sub | 0.137 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.28 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.247 |
CYP2d6-inh | 0.025 |
CYP2d6-sub | 0.348 |
CYP3a4-inh | 0.221 |
CYP3a4-sub | 0.539 |
CL | 1.19 |
T12 | 0.212 |
hERG | 0.722 |
Ames | 0.559 |
ROA | 0.899 |
SkinSen | 0.032 |
Carcinogencity | 0.917 |
EI | 0.005 |
Respiratory | 0.955 |
NR-Aromatase | 0.021 |
Antiviral | Yes |
Prediction | 0.867854 |